Asia Pacific Meningococcal Vaccine Market

Asia Pacific Meningococcal Vaccine Market By Brand (Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands), By Type (Bivalent, Quadrivalent and Other Types), By Age Group (Infants (0 to 2 years) and Children (2 years & above)), By Country, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-5326 Publication Date: February-2021 Number of Pages: 79
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Meningococcal Vaccine Market, by Brand
1.4.2 Asia Pacific Meningococcal Vaccine Market, by Type
1.4.3 Asia Pacific Meningococcal Vaccine Market, by Age Group
1.4.4 Asia Pacific Meningococcal Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Developments in Meningococcal Vaccine Market

Chapter 4. Asia Pacific Meningococcal Vaccine Market by Brand
4.1 Asia Pacific Bexsero Market by Country
4.2 Asia Pacific Trumenba Market by Country
4.3 Asia Pacific Nimenrix Market by Country
4.4 Asia Pacific Menactra Market by Country
4.5 Asia Pacific Menveo Market by Country
4.6 Asia Pacific Other Brands Market by Country

Chapter 5. Asia Pacific Meningococcal Vaccine Market by Type
5.1 Asia Pacific Bivalent Market by Country
5.2 Asia Pacific Quadrivalent Market by Country
5.3 Asia Pacific Other Types Market by Country

Chapter 6. Asia Pacific Meningococcal Vaccine Market by Age Group
6.1 Asia Pacific Children (2 years & above) and Adults Market by Country
6.2 Asia Pacific Infants(0 to 2 years) Market by Country

Chapter 7. Asia Pacific Meningococcal Vaccine Market by Country
7.1 China Meningococcal Vaccine Market
7.1.1 China Meningococcal Vaccine Market by Brand
7.1.2 China Meningococcal Vaccine Market by Type
7.1.3 China Meningococcal Vaccine Market by Age Group
7.2 India Meningococcal Vaccine Market
7.2.1 India Meningococcal Vaccine Market by Brand
7.2.2 India Meningococcal Vaccine Market by Type
7.2.3 India Meningococcal Vaccine Market by Age Group
7.3 Japan Meningococcal Vaccine Market
7.3.1 Japan Meningococcal Vaccine Market by Brand
7.3.2 Japan Meningococcal Vaccine Market by Type
7.3.3 Japan Meningococcal Vaccine Market by Age Group
7.4 South Korea Meningococcal Vaccine Market
7.4.1 South Korea Meningococcal Vaccine Market by Brand
7.4.2 South Korea Meningococcal Vaccine Market by Type
7.4.3 South Korea Meningococcal Vaccine Market by Age Group
7.5 Singapore Meningococcal Vaccine Market
7.5.1 Singapore Meningococcal Vaccine Market by Brand
7.5.2 Singapore Meningococcal Vaccine Market by Type
7.5.3 Singapore Meningococcal Vaccine Market by Age Group
7.6 Malaysia Meningococcal Vaccine Market
7.6.1 Malaysia Meningococcal Vaccine Market by Brand
7.6.2 Malaysia Meningococcal Vaccine Market by Type
7.6.3 Malaysia Meningococcal Vaccine Market by Age Group
7.7 Rest of Asia Pacific Meningococcal Vaccine Market
7.7.1 Rest of Asia Pacific Meningococcal Vaccine Market by Brand
7.7.2 Rest of Asia Pacific Meningococcal Vaccine Market by Type
7.7.3 Rest of Asia Pacific Meningococcal Vaccine Market by Age Group

Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo